News
-
-
-
-
-
-
PRESS RELEASE
Eckert & Ziegler Enters Partnership with Thor Medical to Enable Access of Lead-212 for the Pharmaceutical Industry
Eckert & Ziegler SE partners with Thor Medical to enhance lead-212 access for pharmaceutical industry. Collaboration aims to boost lead-212 based therapies development and production capacity -
-
-
PRESS RELEASE
Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Eckert & Ziegler SE reports strong Q1 results with medical segment driving growth. Isotope Products show recovery potential. Company updates recommendation to BUY with €23 target price. For more details, visit NuWays AG's website -